Ajay Sheshadri, MD, discusses the advantages of attending CHEST 2023 in person and how these benefits can inspire positive change even after the conference ends.
Seeing colleagues in person at the CHEST Annual Meeting 2023 is a valued opportunity after the COVID-19 pandemic and provides advantages for all areas of medicine even after the conference ends, explains Ajay Sheshadri, MD, associate professor of pulmonary medicine at the University of Texas MD Anderson Cancer Center.
Transcript
Why is it beneficial for chest medicine professionals to meet in person at CHEST 2023?
I think we probably took for granted how great it is to see our colleagues in person before the pandemic. During the pandemic, most of our conferences were virtual, and the engagement with the virtual conference is a lot more difficult. You're not there in person seeing the speakers, you're not able to interact with the speakers, other than through a chat box or perhaps a very closely moderated Q&A, and it doesn't quite feel like you're in a research retreat environment.
So, being around people of like-minded interests really just stimulates your own desire to advance the field forward, and I think gives you a lot of energy to be able to motivate yourself when you come back from the conference. Usually, after the conference, there's a little bit of a buzz as you synthesize all the things that you saw and discussed at the conference. To me, that's been incredibly beneficial. Usually after the meetings, there's a flurry of activity and new collaborations and new ideas, and I think you only really get that when you’re there in person and really in the moment.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
Adapting ACA Access Amid Medicaid Transition and Policy Reversals: Molly Dean
February 19th 2025As enrollment shifts to the Affordable Care Act (ACA) marketplace following the unwinding of Medicaid and the Trump administration begins to implement health policy changes, Molly Dean, MSW, Siftwell's policy advisor, shares insight on how to adapt.
Read More